# Millipede AspiRation for Revascularization in Stroke (MARRS) Study

Study · id `cardio:ct-nct05714501` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05714501](<https://clinicaltrials.gov/study/NCT05714501>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05714501

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 235 participants.

## Technical summary

Registry record NCT05714501. Allocation not applicable; no masking; primary purpose treatment. Start 2023-10-09 (actual); primary completion 2025-03-08 (actual). Results posted on 2026-07-10.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 235 participants (enrolled count; ClinicalTrials.gov record NCT05714501, source copy `cardio:ctgov-nct05714501-2026-07-10`, retrieved 2026-10-26)
- Started: 2023-10-09 (actual) (ClinicalTrials.gov record NCT05714501, source copy `cardio:ctgov-nct05714501-2026-07-10`, retrieved 2026-10-26)
- Primary completion: 2025-03-08 (actual) (ClinicalTrials.gov record NCT05714501, source copy `cardio:ctgov-nct05714501-2026-07-10`, retrieved 2026-10-26)
- Completion: 2025-05-12 (actual) (ClinicalTrials.gov record NCT05714501, source copy `cardio:ctgov-nct05714501-2026-07-10`, retrieved 2026-10-26)
- Results first posted: 2026-07-10 (ClinicalTrials.gov record NCT05714501, source copy `cardio:ctgov-nct05714501-2026-07-10`, retrieved 2026-10-26)
- Countries: United States; France; Spain (ClinicalTrials.gov record NCT05714501, source copy `cardio:ctgov-nct05714501-2026-07-10`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05714501-2026-07-10`, retrieved 2026-10-26)

## The registry's words

- Brief title: Millipede AspiRation for Revascularization in Stroke (MARRS) Study
- Acronym: MARRS
- Condition: Acute Ischemic Stroke
- Intervention (Device): Millipede System
- Lead sponsor: Perfuze
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)

## Provenance

Content hash: 92650cf94525811979101395b049659ea077f954ac42f12a28063bd764178c5f
Last substantive edit: 2026-10-31
Evidence last checked: Not recorded
